BELKIN Vision

About

BELKIN Vision is an Israeli medical device company founded in 2013, based in Yavne. The company specializes in innovative glaucoma laser therapy solutions, particularly through its core product, the BELKIN Eagle™. This automated, non-contact device is designed for Direct Selective Laser Trabeculoplasty (DSLT) procedures, which help lower intraocular pressure in patients with glaucoma. The technology allows for fast and noninvasive treatment, making it accessible to general ophthalmologists. BELKIN Vision's approach addresses the challenges of traditional glaucoma treatments, such as daily eye drops, which can lead to non-compliance among patients. The company aims to improve glaucoma care for approximately 140 million people worldwide. BELKIN Eagle™ is currently available in the EU and UK and is undergoing FDA review for potential availability in the US. The company has established partnerships with notable medical centers and technology providers, enhancing its development and outreach in the field of glaucoma treatment.